Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05557370 · ClinicalTrials.gov registry record · Phase 4
Immunogenicity of HPV Vaccine in Transplant Recipients.
A Phase 4 study of Chronic Kidney Diseases and Kidney Transplant, sponsored by Medical College of Wisconsin.
- Active
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05557370: Active Phase 4 study of Chronic Kidney Diseases and Kidney Transplant, sponsored by Medical College of Wisconsin.
NCT05557370 is a Phase 4 study of Chronic Kidney Diseases and Kidney Transplant that is active but no longer recruiting, run by Medical College of Wisconsin. The registered enrollment target is 30 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05557370, a Phase 4 study of Chronic Kidney Diseases and Kidney Transplant, is active but no longer recruiting, sponsored by Medical College of Wisconsin.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
Primary Outcome
The primary outcome is to measure immunogenicity using the Merck proprietary Competitive Luminex Immunoassay (cLIA) and geometric mean titers (GMTs) over specified time intervals (7 months, 12 months and 24 months from vaccination) in patients to each of the nine human papillomavirus types contained in the nanovalent human papillomavirus vaccine (HPV9) vaccination and compare these antibody levels to published control data for non-immunocompromised individuals. this has been completed previously
Conditions Studied
Interventions
- BIOLOGICAL Human Papilloma Virus vaccine (GARDASIL 9)
Study Locations (1)
Wisconsin
- Froedtert Lutheran Memorial Hospital - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2035-12-31 |
| Phase | Phase 4 |
What the registry record for NCT05557370 still lists
NCT05557370 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Human Papilloma Virus vaccine (GARDASIL 9) is the first listed.
NCT05557370 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05557370 about?
NCT05557370 is a clinical study titled "Immunogenicity of HPV Vaccine in Transplant Recipients.". To measure levels of HPV antibodies in post-solid-organ transplant recipients who have gotten the HPV9 vaccine.
What is the current status of trial NCT05557370?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2023-06-01. Estimated completion is 2035-12-31.
What conditions does trial NCT05557370 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Kidney Transplant.
What interventions are being tested in trial NCT05557370?
The interventions under investigation include: Human Papilloma Virus vaccine (GARDASIL 9) (BIOLOGICAL).
Who is sponsoring clinical trial NCT05557370?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05557370 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05557370's enrollment target sits among peer trials
30 61st of 73 higher than 8 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Iron in Children With Chronic Kidney Disease
RECRUITING · Phase 4
-
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
RECRUITING · Phase 4
-
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
RECRUITING · Phase 4
-
Ferric Citrate in ESRD Pilot Project
ACTIVE NOT RECRUITING · Phase 4
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI